igenica biotherapeutics

Antibody drug conjugate player Igenica Biotherapeutics raises $5M

Igenica Biotherapeutics – a biotech star-studded with execs that, in previous career incarnations brought a number of antibody drug conjugate drugs to market – just raised a modest round of funding to further develop its own ADCs. The Bay Area startup brought in $5 million of a proposed $6.25 million round, according to a regulatory filing. This […]